US FDA approves Vanda Pharmaceuticals' motion sickness drug

Core Viewpoint - Vanda Pharmaceuticals has received approval from the U.S. health regulator for its drug aimed at preventing motion-induced vomiting, marking the first treatment for this condition in over 40 years [1] Company Summary - Vanda Pharmaceuticals' new drug is significant as it addresses a long-standing gap in treatment options for motion-induced vomiting, which has not seen a new approved therapy in four decades [1]